3 Bitcoin Mining Stocks to Watch in the Third Week of November 2025

When looking at Bitcoin price, concerns should not be limited to altcoins but should also extend to companies involved in BTC related activities.

In that same vein, BeInCrypto analyzed the stock performance of three Bitcoin mining companies and what awaits them in the coming period.

BitMine Immersion Technologies (BMNR)

BMNR has fallen 24% this week and is currently trading at $30.95. Despite the decline, Bitmine continues to accumulate ETH, adding 54,156 ETH worth over $170 million in the past seven days. This shows strong long-term confidence from the company.

RSI is approaching oversold territory, which typically signals a reversal. If conditions stabilize, BMNR could rebound from the $30.88 support and climb to $34.94 or even $37.27, providing some relief after a week of heavy losses.

Want more Token news like this? Sign up for Editor Harsh Notariya's daily Crypto Newsletter here .

If Bitcoin weakens further, BMNR could follow the overall downtrend. A deeper decline could take the stock below $27.80, with a potential drop to $24.64. This would invalidate the uptrend and signal more downside momentum.

Bitdeer Technologies Group (BTDR)

Bitdeer has recorded some of the steepest declines among Bitcoin mining stocks , falling 53% in seven trading sessions. Its current share price of $10.63 reflects heavy selling pressure as broader market weakness continues to weigh on miners.

BTDR's RSI is deep in oversold territory, signaling conditions that typically precede a reversal. If there is support from buyers, the stock could rebound from $9.56 and advance to $11.92, with the potential to rise higher to $15.24 if momentum strengthens.

If market conditions do not improve, BTDR could continue to decline. If it falls below $9.56, the price could reach $7.96. This would invalidate the uptrend and signal a long-term decline for the mining company .

HIVE Digital Technologies Ltd. (HIVE)

Bitcoin mining company HIVE has fallen 29% over the past week but is now trading at $3.56 after rising 7.5% today. The rally follows the company's announcement of 285% revenue growth in Q2, which has boosted investor confidence despite recent volatility.

This strong performance could spark a broader recovery and push HIVE to $4.04. Recovering recent losses would require a rise to $5.09. Reaching this target could take time, but is still possible if momentum and sentiment continue to improve.

If the stock fails to capitalize on the company’s earnings strength, HIVE could continue to fall. A break below the $3.00 support level would invalidate the bullish thesis and signal renewed weakness.